Anti-arrhythmic Drugs in Atrial Fibrillation: Historical Perspectives and New Developments

  • Berndt Lüeritz
Conference paper


The treatment of atrial fibrillation (AF) remains challenging in everyday practice. Even with the introduction of catheter ablation, decision-making about the type of therapy has become more complex. The recently published guidelines of the American College of Cardiology, American Heart Association, and the European Society of Cardiology clearly show the therapeutic approaches for the different types of AF (Fig. 1).


Atrial Fibrillation Sinus Rhythm Catheter Ablation Paroxysmal Atrial Fibrillation Atrial Fibrillation Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fuster V, Ryden LE, Cannom DS et al (2006) 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:700–752CrossRefGoogle Scholar
  2. 2.
    Feinberg WM, Blackshear JL, Laupacis A et al (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469–473PubMedCrossRefGoogle Scholar
  3. 3.
    Benjamin EJ, Levy D, Vaziri SM et al (1994) Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271:840–844PubMedCrossRefGoogle Scholar
  4. 4.
    Kannel WB, Wolf PA, Benjamin EJ et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9NPubMedCrossRefGoogle Scholar
  5. 5.
    Krahn AD, Manfreda J, Tate RB et al (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Cardiol 98:476–484Google Scholar
  6. 6.
    Benjamin EJ, Wolf PA, D’Agostino RB et al (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952PubMedGoogle Scholar
  7. 7.
    Lüeritz B, Jung W (2000) Quality of life in patients with atrial fibrillation. Arch Intern Med 160:1749–1757CrossRefGoogle Scholar
  8. 8.
    Wyse DG (2000) The AFFIRM trial: main trial and substudies — what can we expect? J Interv Card Electrophysiol 4:171–176PubMedCrossRefGoogle Scholar
  9. 9.
    Jung W, Lüeritz B (1998) Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol 9(Suppl 8):S177–S186PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Berndt Lüeritz
    • 1
  1. 1.Department of Medicine - CardiologyUniversity of BonnBonnGermany

Personalised recommendations